You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Johnson and Johnson
Colorcon
Moodys
Boehringer Ingelheim

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc. (S.D.N.Y. 2012)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc. (S.D.N.Y. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-04-26 4 the three Low ABUK patents and two additional patents: U.S. Patent No. 6,488,963, titled “Hot-Melt Extrudable…involve a fourth patent, U.S. Patent No. 5,508,042 (“the ‘042 patent”), one of the patents in suit in the… is an action for relief from patent infringement The three U.S. patents at issue are listed in the U.…is presiding over eleven actions for patent infringement of patents relating to Purdue’s original OxyContin…the “2012 Vamm” action). 3 These three patents are U.S. Patent No. 7,674,799, No. 7,674,800, and No. 7,683,072 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Baxter
Dow
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.